Document Detail


The use of topical calcineurin inhibitors in lupus erythematosus: an overview.
MedLine Citation:
PMID:  18005117     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Lupus erythematosus (LE) shows a broad range of cutaneous symptoms, including acute, subacute and chronic lesions. The gold standard of established topical treatment consists of medium- to high-potency corticosteroids. Because face and neck are often involved, adverse effects of prolonged corticosteroid use are not uncommon. There is a need of steroid-free topical treatment in LE. With the development of topical calcineurin inhibitors, tacrolimus and pimecrolimus, there is an alternative available. The present study reviews the literature data on topical tacrolimus and pimecrolimus for malar rash, subacute lesions and discoid chronic lesions among others. The present data argue for an efficacy of these compounds in acute and subacute cutaneous LE manifestations with a rapid response and only minor side-effects when used as an adjunct to systemic treatment. In chronic discoid LE, hypertrophic plaques do not well respond because of limited penetration. The primary target seems to be the decrease or blocking of cytokine production by activated T lymphocytes.
Authors:
U Wollina; G Hansel
Related Documents :
21458037 - Intratesticular varix.
2502337 - Cutaneous manifestations of dysproteinemias.
21285687 - Usefulness of f-18 fdg pet/ct in a case of kaposi sarcoma with an unexpected bone lesion.
1831117 - Vaginal ulcerations due to lithium carbonate therapy.
11808857 - Large demyelinating brain lesion mimicking a herniating tumor.
23119867 - A comparative study of fine needle aspiration cytology, ultrasonography and radionuclid...
Publication Detail:
Type:  Journal Article; Review     Date:  2007-11-12
Journal Detail:
Title:  Journal of the European Academy of Dermatology and Venereology : JEADV     Volume:  22     ISSN:  1468-3083     ISO Abbreviation:  J Eur Acad Dermatol Venereol     Publication Date:  2008 Jan 
Date Detail:
Created Date:  2008-01-09     Completed Date:  2008-03-27     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  9216037     Medline TA:  J Eur Acad Dermatol Venereol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  1-6     Citation Subset:  IM    
Affiliation:
Department of Dermatology and Allergology, Academic Teaching Hospital Dresden-Friedrichstadt, Dresden, Germany. wollina-uw@khdf.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Topical
Calcineurin / antagonists & inhibitors*
Cytokines / metabolism
Female
Humans
Immunosuppressive Agents / administration & dosage,  adverse effects,  therapeutic use*
Lupus Erythematosus, Systemic / drug therapy*,  metabolism
Male
Tacrolimus / administration & dosage,  adverse effects,  analogs & derivatives,  therapeutic use
Chemical
Reg. No./Substance:
0/Cytokines; 0/Immunosuppressive Agents; 0/pimecrolimus; 109581-93-3/Tacrolimus; EC 3.1.3.16/Calcineurin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Keratin and filaggrin expression in keratoacanthoma.
Next Document:  Alopecia areata: topical immunotherapy treatment with diphencyprone.